This suggestion is consistent with previous observations indicating that elevated expression of both of these STAT proteins is seen in numerous cancers, where their phosphorylation results in enhanced expression of cell cycle progression (e.g., cyclin D1 [49, 50]) and survival (e.g., Bcl-xL and Bcl-2 [51–53]) genes. The gene discussed is BCL2L1; the disease is cancer.